Achieve Life Sciences (ACHV) Shares Outstanding (2010 - 2026)
Achieve Life Sciences (ACHV) posted Shares Outstanding (Entity) of $412320.0 for Q4 2019, up 1.77% on a QoQ basis from $405138.0 in Q3 2019, and up 134.93% year-over-year from $175511.0 in Q4 2018.
Achieve Life Sciences (ACHV) Shares Outstanding (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $412320.0 for Q4 2019.
- Quarterly Shares Outstanding (Entity) rose 134.93% year-over-year to $412320.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $412320.0 (up 134.93% YoY) and the FY2019 annual result came in at $412320.0, up 134.93% from the prior year.
- Shares Outstanding (Entity) was $412320.0 for Q4 2019 at Achieve Life Sciences, up from $405138.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $412320.0 in Q4 2019 and bottomed at $10313.0 in Q1 2015.
- A 5-year average of $115494.1 and a median of $18835.5 in 2017 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2017 — Shares Outstanding (Entity) advanced 0.31% — and 2018, when it surged 632.15%.
- Achieve Life Sciences' Shares Outstanding (Entity) stood at $13567.0 in 2015, then increased by 0.71% to $13664.0 in 2016, then jumped by 75.44% to $23972.0 in 2017, then jumped by 632.15% to $175511.0 in 2018, then surged by 134.93% to $412320.0 in 2019.
- Business Quant data shows ACHV's Shares Outstanding (Entity) at $412320.0 in Q4 2019, $405138.0 in Q3 2019, and $404888.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | 53.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.38 Mn |
| Dec 31, 2025 | 43.59 Mn |
| Sep 30, 2025 | 51.02 Mn |
| Jun 30, 2025 | 34.69 Mn |
| Mar 31, 2025 | 34.69 Mn |
| Dec 31, 2024 | 32.07 Mn |
| Sep 30, 2024 | 34.36 Mn |
| Jun 30, 2024 | 34.32 Mn |
| Mar 31, 2024 | 25.05 Mn |
| Dec 31, 2023 | 19.83 Mn |
| Sep 30, 2023 | 21.13 Mn |
| Jun 30, 2023 | 19.05 Mn |
| Mar 31, 2023 | 17.92 Mn |
| Dec 31, 2022 | 10.59 Mn |
| Sep 30, 2022 | 9.69 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 9.46 Mn |
| Dec 31, 2021 | 8.12 Mn |
| Sep 30, 2021 | 9.45 Mn |
| Jun 30, 2021 | 7.39 Mn |